SugenTech Inc
KOSDAQ:253840
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ultrapar Participacoes SA
BOVESPA:UGPA3
|
BR |
SugenTech Inc
Cash from Operating Activities
SugenTech Inc
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SugenTech Inc
KOSDAQ:253840
|
Cash from Operating Activities
-₩14.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Cash from Operating Activities
₩20.1B
|
CAGR 3-Years
45%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-1%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Cash from Operating Activities
₩163.9B
|
CAGR 3-Years
44%
|
CAGR 5-Years
34%
|
CAGR 10-Years
135%
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Cash from Operating Activities
₩14.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Cash from Operating Activities
₩31.2B
|
CAGR 3-Years
58%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Cash from Operating Activities
-₩11.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
SugenTech Inc
Glance View
Sugentech, Inc. develops in-vitro diagnostic systems and products. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2016-11-11. The firm is involved in the manufacturing and sale of in vitro diagnostic test reagents, point-of-care testing (POCT) products, folic acid products under the name of SOLGAR, as well as molecular diagnostic reagents. The in vitro diagnostic test reagents are for personal use and are sold under the name SUREARLY. The POCT products are for professional use and are sold under the name INCLIX. In addition, the Company is engaged in therapeutic drug monitoring, as well as drug analysis method development. The firm distributes its products within the domestic market and to overseas markets, including Indonesia.
See Also
What is SugenTech Inc's Cash from Operating Activities?
Cash from Operating Activities
-14.6B
KRW
Based on the financial report for Dec 31, 2025, SugenTech Inc's Cash from Operating Activities amounts to -14.6B KRW.
What is SugenTech Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 1Y
-95%
Over the last year, the Cash from Operating Activities growth was -95%.
